DCF — LOVELACE MEDICAL CENTER- DOWNTOWN
Enterprise Value: $-591.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-591.8M
Enterprise Value
$-186.5M
PV of Cash Flows
$-405.3M
PV of Terminal Value
$-652.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $348.5M | $-37.3M | -11.0% | $-52.0M | $-47.3M |
| Year 2 | $359.0M | $-34.8M | -10.0% | $-50.0M | $-41.3M |
| Year 3 | $369.7M | $-32.1M | -9.0% | $-47.8M | $-35.9M |
| Year 4 | $380.8M | $-31.2M | -8.0% | $-47.3M | $-32.3M |
| Year 5 | $392.3M | $-31.2M | -8.0% | $-47.8M | $-29.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-591.8M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$338.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.11193848153853571
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5